|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| A61K 39/00 |
| (11) | Number of the document | 2260055 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09715176.5 |
| Date of filing the European patent application | 2009-02-27 | |
| (97) | Date of publication of the European application | 2010-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/001437 |
| Date | 2009-02-27 |
| (87) | Number | WO 2009/106356 |
| Date | 2009-09-03 |
| (30) | Number | Date | Country code |
| 32707 P | 2008-02-29 | US | |
| 90743 P | 2008-08-21 | US |
| (72) |
MÜLLER, Bernhard, K., DE
SCHMIDT, Martin, DE
BARLOW, Eve, H., US
LEDDY, Mary, R., US
HSIEH, Chung-ming, US
BARDWELL, Phillip, D., US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
AbbVie Deutschland GmbH & Co KG, Max-Planck-Ring 2a, 65205 Wiesbaden, DE |
| (54) | MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF |
| MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF |